Table 4.
Patient number | Etiology | Liver transplant (yes/no) |
Sustained ICP elevation (yes/no) | TIL (basic) | GOS at discharge | GOS at 6 months |
---|---|---|---|---|---|---|
1 | Epstein Barr virus | Yes | Yes | 2 | 4 | 5 |
2 | Idiopathic | Yes | No | 1 | 3 | 5 |
3 | Hepatitis B | Yes | Yes | 2 | 3 | 3 |
4 | Acetaminophen | No | No | 1 | 4 | N/A |
5 | Acetaminophen | No | No | 1 | 3 | N/A |
6 | Ischemic | No | Yes | 2 | 3 | 3 |
7 | Highly active anti-retroviral therapy | No | No | 1 | 3 | N/A |
8 | Acetaminophen | No | Yes | 2 | 4 | N/A |
9 | Acetaminophen | No | No | 1 | 4 | N/A |
10 | Acetaminophen | No | Yes | 4 | 3 | 5 |
11 | Acetaminophen | No | Yes | 2 | 4 | N/A |
12a | Acetaminophen | No | No | 1 | 3 | 5 |
Descriptive table of patients who underwent invasive intracranial pressure monitoring (IICPM), and were alive at discharge, with individual functional outcomes ICP intracranial pressure, GOS Glasgow Outcome Scale, TIL therapeutic intensity level, N/A Not Applicable
aThe only patient to suffer a complication of IICPM - an asymptomatic 6-mm subdural hematoma